| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Internal Medicine III and
Biochemistry, Nagoya University School of Medicine, Nagoya, Japan
Midkine (MK) is a multifunctional heparin-binding protein and promotes migration of neutrophils, macrophages, and neurons. In the normal mouse kidney, MK is expressed in the proximal tubules. After renal ischemic reperfusion injury, its expression in proximal tubules was increased. Immediate increase of MK expression was found when renal proximal tubular epithelial cells in culture were exposed to 5 mM H2O2. Histologically defined tubulointerstitial damage was less severe in MK-deficient (Mdk-/-) than in wild-type (Mdk+/+) mice at 2 and 7 days after ischemic reperfusion injury. Within 2 days after ischemic injury, inflammatory leukocytes, of which neutrophils were the major population, were recruited to the tubulointerstitium. The numbers of infiltrating neutrophils and also macrophages were lower in Mdk-/- than in Mdk+/+ mice. Induction of macrophage inflammatory protein-2 and macrophage chemotactic protein-1, chemokines for neutrophils and macrophages, respectively, were also suppressed in Mdk-/- mice. Furthermore, renal tubular epithelial cells in culture expressed macrophage inflammatory protein-2 in response to exogenous MK administration. These results suggested that MK enhances migration of inflammatory cells upon ischemic injury of the kidney directly and also through induction of chemokines, and contributes to the augmentation of ischemic tissue damage.
This article has been cited by other articles:
|
|
 |
|
  J. Floege and S. Uhlig Kidney calling lung and call back: how organs talk to each other Nephrol. Dial. Transplant., September 15, 2009; (2009) gfp464v1. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kato, Y. Yuzawa, T. Kosugi, A. Hobo, W. Sato, Y. Miwa, K. Sakamoto, S. Matsuo, and K. Kadomatsu The E-Selectin Ligand Basigin/CD147 Is Responsible for Neutrophil Recruitment in Renal Ischemia/Reperfusion J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1565 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Furuichi, J.-L. Gao, R. Horuk, T. Wada, S. Kaneko, and P. M. Murphy Chemokine Receptor CCR1 Regulates Inflammatory Cell Infiltration after Renal Ischemia-Reperfusion Injury J. Immunol., December 15, 2008; 181(12): 8670 - 8676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Urahama, Y. Ohsaki, Y. Fujita, S. Maruyama, Y. Yuzawa, S. Matsuo, and T. Fujimoto Lipid Droplet-Associated Proteins Protect Renal Tubular Cells from Fatty Acid-Induced Apoptosis Am. J. Pathol., November 1, 2008; 173(5): 1286 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Basile, K. Fredrich, B. Chelladurai, E. C. Leonard, and A. R. Parrish Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor Am J Physiol Renal Physiol, April 1, 2008; 294(4): F928 - F936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, H. Takeuchi, Y. Sonobe, S. Jin, T. Mizuno, S. Miyakawa, M. Fujiwara, Y. Nakamura, T. Kato, H. Muramatsu, et al. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population PNAS, March 11, 2008; 105(10): 3915 - 3920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fukui, S. Kitagawa-Sakakida, S. Kawamata, G. Matsumiya, N. Kawaguchi, N. Matsuura, and Y. Sawa Therapeutic Effect of Midkine on Cardiac Remodeling in Infarcted Rat Hearts Ann. Thorac. Surg., February 1, 2008; 85(2): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ichihara-Tanaka, A. Oohira, M. Rumsby, and T. Muramatsu Neuroglycan C Is a Novel Midkine Receptor Involved in Process Elongation of Oligodendroglial Precursor-like Cells J. Biol. Chem., October 13, 2006; 281(41): 30857 - 30864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. D. Pecly, R. G. Goncalves, E. P. Rangel, C. M. Takiya, F. S. Taboada, C. A. Martinusso, M. S. G. Pavao, and M. Leite Jr Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-{beta}, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1212 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Inoh, H. Muramatsu, S. Torii, S. Ikematsu, M. Oda, H. Kumai, S. Sakuma, T. Inui, T. Kimura, and T. Muramatsu Doxorubicin-Conjugated Anti-Midkine Monoclonal Antibody as a Potential Anti-Tumor Drug Jpn. J. Clin. Oncol., April 1, 2006; 36(4): 207 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kosugi, Y. Yuzawa, W. Sato, H. Kawai, S. Matsuo, Y. Takei, T. Muramatsu, and K. Kadomatsu Growth Factor Midkine Is Involved in the Pathogenesis of Diabetic Nephropathy Am. J. Pathol., January 1, 2006; 168(1): 9 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mizuno and T. Nakamura Prevention of Neutrophil Extravasation by Hepatocyte Growth Factor Leads to Attenuations of Tubular Apoptosis and Renal Dysfunction in Mouse Ischemic Kidneys Am. J. Pathol., June 1, 2005; 166(6): 1895 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2203 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, W. Sato, Y. Yuzawa, T. Kosugi, S. Matsuo, Y. Takei, K. Kadomatsu, and T. Muramatsu Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage Am. J. Pathol., November 1, 2004; 165(5): 1603 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Muramatsu, P. Zou, H. Suzuki, Y. Oda, G.-Y. Chen, N. Sakaguchi, S. Sakuma, N. Maeda, M. Noda, Y. Takada, et al. {alpha}4{beta}1- and {alpha}6{beta}1-integrins are functional receptors for midkine, a heparin-binding growth factor J. Cell Sci., October 15, 2004; 117(22): 5405 - 5415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kato, Y. Yuzawa, N. Tsuboi, S. Maruyama, Y. Morita, T. Matsuguchi, and S. Matsuo Endotoxin-Induced Chemokine Expression in Murine Peritoneal Mesothelial Cells: The Role of Toll-Like Receptor 4 J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1289 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Suzuki, Y. Shibata, T. Urano, T. Murohara, T. Muramatsu, and K. Kadomatsu Proteasomal Degradation of the Nuclear Targeting Growth Factor Midkine J. Biol. Chem., April 23, 2004; 279(17): 17785 - 17791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Morrisey and R. C. Savani Midkine: A Potential Bridge between Glucocorticoid and Retinoid Effects on Lung Vascular Development Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 5 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zou, K. Zou, H. Muramatsu, K. Ichihara-Tanaka, O. Habuchi, S. Ohtake, S. Ikematsu, S. Sakuma, and T. Muramatsu Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor Glycobiology, January 1, 2003; 13(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sumi, H. Muramatsu, Y. Takei, K.-I. Hata, M. Ueda, and T. Muramatsu Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model J. Cell Sci., January 7, 2002; 115(13): 2659 - 2667. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
